Company: NCEL
Filing Date: 2025-09-25
Form Type: F-1
Source: 0001213900-25-091697
Chunk: 125

Company: NewcelX Ltd.
Filing Date: 2025-09-25
Form: F-1
Chunk 125
---
 $3.97, for aggregate gross proceeds
of $3.2 million. The warrants have a term of five years and an exercise price of $4.25 per share. Investors were granted the
right to participate in up to 50% of future offerings for one year following the closing. We also agreed not to enter into an equity line
of credit or similar agreement without the consent of the majority of the preferred shareholders. The transaction closed on October 10,
2024.

Also on October 9, 2024,
we entered into a securities purchase agreement with an accredited investor to satisfy $4.0 million of our debt by issuing 806,452
newly designated convertible Preferred Shares at a purchase price of $4.96 per share (the “Preferred Shares”). The Preferred
Shares have a conversion price of $4.96 per share. The investor was granted the right to purchase up to an additional $10.0 million
worth of convertible Preferred Shares starting six months after the closing and continuing as long as they own Preferred Shares.
The investor also has the right to participate in up to 50% of future offerings for one year following the closing. We agreed not to enter
into an equity line of credit or similar agreement without the consent of the majority of the preferred shareholders. This transaction
also closed on October 10, 2024.

<div align='center'>II-2</div>

On October 9, 2024, we
and certain existing warrant holders entered into warrant amendment agreements (collectively, the “October Warrant Amendment”),
to amend those warrants issued by Company to such holders, collectively, to purchase up to 105,843 Common Shares issued to such holders
(the “Existing Warrants”). The October Warrant Amendment makes certain adjustment to the definition of a “Fundamental
Transaction” in Section 3(e) of the Existing Warrants. In exchange for the October Warrant Amendment, we agreed to adjust the
exercise price in the Common Warrants to CHF 0.80 and issued to the holders pre-funded warrants to purchase up to 136,648 Common Shares
(the “October Pre-Funded Warrants”). Each October Pre-Funded Warrant is exercisable for one Common Share at an exercise price
of CHF 0.80 per share. The October Pre-Funded Warrants are immediately exercisable and may be exercised at any time until all of the October
Pre-Funded Warrants are exercised in full.

On October 10